149 related articles for article (PubMed ID: 24225229)
1. The expression and clinical significance of HERC4 in breast cancer.
Zhou H; Shi R; Wei M; Zheng WL; Zhou JY; Ma WL
Cancer Cell Int; 2013 Nov; 13(1):113. PubMed ID: 24225229
[TBL] [Abstract][Full Text] [Related]
2. Expression of HERC4 in lung cancer and its correlation with clinicopathological parameters.
Zeng WL; Chen YW; Zhou H; Zhou JY; Wei M; Shi R
Asian Pac J Cancer Prev; 2015; 16(2):513-7. PubMed ID: 25684480
[TBL] [Abstract][Full Text] [Related]
3. [Expression of E3 ligase HERC4 in breast cancer and its clinical implications].
Zhou H; Shi R; Chen Y; Zeng W; Liang S; Zheng W; Ma W
Nan Fang Yi Ke Da Xue Xue Bao; 2014 Jul; 34(8):1110-4. PubMed ID: 25176076
[TBL] [Abstract][Full Text] [Related]
4. HERC4 Is Overexpressed in Hepatocellular Carcinoma and Contributes to the Proliferation and Migration of Hepatocellular Carcinoma Cells.
Zheng Y; Li J; Pan C; Zhou G; Zhuge L; Jin L; Fang P
DNA Cell Biol; 2017 Jun; 36(6):490-500. PubMed ID: 28430527
[TBL] [Abstract][Full Text] [Related]
5. A miRNA-HERC4 pathway promotes breast tumorigenesis by inactivating tumor suppressor LATS1.
Xu Y; Ji K; Wu M; Hao B; Yao KT; Xu Y
Protein Cell; 2019 Aug; 10(8):595-605. PubMed ID: 30710319
[TBL] [Abstract][Full Text] [Related]
6. Decreased expression of Sushi Domain Containing 2 correlates to progressive features in patients with hepatocellular carcinoma.
Liu XR; Cai CX; Luo LM; Zheng WL; Shi R; Zeng J; Xu YQ; Wei M; Ma WL
Cancer Cell Int; 2016; 16():15. PubMed ID: 26933386
[TBL] [Abstract][Full Text] [Related]
7. SAV1, regulated by HERC4, inhibits the proliferation, migration, and invasion of hepatocellular carcinoma.
Huang F; Tang X; Sun T; Wang G; Ru Q; Zheng Y
Transl Cancer Res; 2021 Jan; 10(1):349-360. PubMed ID: 35116265
[TBL] [Abstract][Full Text] [Related]
8. HERC4 modulates ovarian cancer cell proliferation by regulating SMO-elicited hedgehog signaling.
Zhu Q; Yang X; Lv Y
Biochim Biophys Acta Gen Subj; 2024 Apr; 1868(4):130557. PubMed ID: 38181892
[TBL] [Abstract][Full Text] [Related]
9. Clinicopathological significance of stromal myofibroblasts in invasive ductal carcinoma of the breast.
Yazhou C; Wenlv S; Weidong Z; Licun W
Tumour Biol; 2004; 25(5-6):290-5. PubMed ID: 15627894
[TBL] [Abstract][Full Text] [Related]
10. Increased N-myc downstream-regulated gene 1 expression is associated with breast atypia-to-carcinoma progression.
Mao XY; Fan CF; Wei J; Liu C; Zheng HC; Yao F; Jin F
Tumour Biol; 2011 Dec; 32(6):1271-6. PubMed ID: 21909787
[TBL] [Abstract][Full Text] [Related]
11. A non-invasive modality: the US virtual touch tissue quantification (VTTQ) for evaluation of breast cancer.
Tamaki K; Tamaki N; Kamada Y; Uehara K; Miyashita M; Ishida T; Sasano H
Jpn J Clin Oncol; 2013 Sep; 43(9):889-95. PubMed ID: 23911773
[TBL] [Abstract][Full Text] [Related]
12. The expression patterns and correlations of claudin-6, methy-CpG binding protein 2, DNA methyltransferase 1, histone deacetylase 1, acetyl-histone H3 and acetyl-histone H4 and their clinicopathological significance in breast invasive ductal carcinomas.
Xu X; Jin H; Liu Y; Liu L; Wu Q; Guo Y; Yu L; Liu Z; Zhang T; Zhang X; Dong X; Quan C
Diagn Pathol; 2012 Mar; 7():33. PubMed ID: 22455563
[TBL] [Abstract][Full Text] [Related]
13. Low expression of PinX1 is associated with malignant behavior in basal-like breast cancer.
Feng YZ; Zhang QY; Fu MT; Zhang ZF; Wei M; Zhou JY; Shi R
Oncol Rep; 2017 Jul; 38(1):109-119. PubMed ID: 28586040
[TBL] [Abstract][Full Text] [Related]
14. EIF5A expression and its role as a potential diagnostic biomarker in hepatocellular carcinoma.
Li L; Li X; Zhang Q; Ye T; Zou S; Yan J
J Cancer; 2021; 12(16):4774-4779. PubMed ID: 34234848
[No Abstract] [Full Text] [Related]
15. Expression of TMEM40 in bladder cancer and its correlation with clinicopathological parameters.
Zhang QY; Fu MT; Zhang ZF; Feng YZ; Wei M; Zhou JY; Shi R
Int J Clin Exp Pathol; 2017; 10(7):8050-8057. PubMed ID: 31966657
[TBL] [Abstract][Full Text] [Related]
16. Identification of stage-specific breast markers using quantitative proteomics.
Shaheed SU; Rustogi N; Scally A; Wilson J; Thygesen H; Loizidou MA; Hadjisavvas A; Hanby A; Speirs V; Loadman P; Linforth R; Kyriacou K; Sutton CW
J Proteome Res; 2013 Dec; 12(12):5696-708. PubMed ID: 24106833
[TBL] [Abstract][Full Text] [Related]
17. The ubiquitin ligase HERC4 mediates c-Maf ubiquitination and delays the growth of multiple myeloma xenografts in nude mice.
Zhang Z; Tong J; Tang X; Juan J; Cao B; Hurren R; Chen G; Taylor P; Xu X; Shi CX; Du J; Hou J; Wang G; Wu D; Stewart AK; Schimmer AD; Moran MF; Mao X
Blood; 2016 Mar; 127(13):1676-86. PubMed ID: 26825710
[TBL] [Abstract][Full Text] [Related]
18. [Expression and significance of TRAF4 protein in breast carcinoma].
Dai WB; Zheng YW; Mi XY; Liu N; Lin H; Yan J
Ai Zheng; 2007 Oct; 26(10):1095-8. PubMed ID: 17927880
[TBL] [Abstract][Full Text] [Related]
19. Correlated expression of Fas, NF-kappaB, and VEGF-C in infiltrating ductal carcinoma of the breast.
Dai XL; Zhou SL; Qiu J; Liu YF; Hua H
Eur J Gynaecol Oncol; 2012; 33(6):633-9. PubMed ID: 23327061
[TBL] [Abstract][Full Text] [Related]
20. Reduced expression of PinX1 correlates to progressive features in patients with prostate cancer.
Shi R; Zhao Z; Zhou H; Wei M; Ma WL; Zhou JY; Tan WL
Cancer Cell Int; 2014; 14():46. PubMed ID: 24936151
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
